Financial report for FY 2023Q3
Subject: The Company's consolidated financial report for FY 2023Q3 has been approved by the Board of Directors
Contents:
1.Date of submission to the board of directors or approval by the board of directors:2023/11/14
2.Date of approval by the audit committee:2023/11/14
3.Start and end dates of financial reports or annual self-assessed financial information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):2023/01/01~2023/09/30
4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):4,310,149,182
5.Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):274,665,136
6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):117,598,322
7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):125,325,930
8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):96,532,343
9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):88,953,088
10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):6.42
11.Total assets end of the period (thousand NTD):4,063,389,195
12.Total liabilities end of the period (thousand NTD):2,376,251,282
13.Equity attributable to owners of parent end of the period (thousand NTD):1,484,999,679
14.Any other matters that need to be specified: None.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 7 minutes ago Kainos Group
- 1 hour ago Avon Technologies plc
- 1 hour ago TBC Bank Group
- 2 hours ago Moneysupermarket.com Group
- 2 hours ago Dr. Martens